Advancing Skills Through Consultation, Education, and Novel Technologies (ASCENT)
Increasing the Reach of Evidence-Based PTSD Treatment: Development and Clinical Trial of Artificial Intelligence (AI)-Facilitated, Web-Based Written Exposure Therapy Training
This research study tests strategies to train behavioral health providers in Written Exposure Therapy (WET), an evidence-based treatment for posttraumatic stress disorder (PTSD). There are a number of evidence-based treatments for posttraumatic stress disorder (PTSD). However, most behavioral health providers have not received training in these PTSD treatments and do not offer them regularly to their patients.
The researchers hope to learn about the optimal way to train behavioral providers in this type of treatment. This study is designed to determine the comparative effectiveness of different training strategies on key outcomes such as how much competency providers develop in the therapy and to how many patients they deliver the therapy. This study will help the researchers understand if we can help more providers learn to competently delivery Written Exposure Therapy by using strategies that are more convenient and cost less money, including web-based and AI-facilitated training supports. This study will also help us learn which training strategies work best for which providers so that in the future we can make personalized training recommendations.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This study will enroll behavioral health providers (i.e., professional therapists) and test a training program for Written Exposure Therapy that includes
- an enhanced, web-based foundational training (web-based training plus integrated TherapyTrainer components) and
- an AI training support tool for competency development (TherapyTrainer).
This randomized clinical trial will compare web/AI training, among providers who serve Veterans and Service Members, to standard Written Exposure Therapy training (i.e., human-delivered live workshop and consultation calls) on provider, patient, and cost-effectiveness outcomes. There is no cross-over of conditions. Providers in both conditions will be eligible to earn continuing education credits and approval as Written Exposure Therapy Providers who have completed competency based training and two training cases.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Stefanie Losavio, PhD
- Numéro de téléphone: (210) 562-6714
- E-mail: ASCENT@uthscsa.edu
Lieux d'étude
-
-
Texas
-
San Antonio, Texas, États-Unis, 78229
- Recrutement
- University of Texas Health Science Center at San Antonio
-
Contact:
- Stefanie LoSavio, PhD
- Numéro de téléphone: 210-562-6714
- E-mail: losavio@uthscsa.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- mental health provider;
- serves veterans and/or service members with PTSD (by self-report);
- willing to participate in either live or web-based training.
Exclusion Criteria:
1. has already completed formal training in Written Exposure Therapy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Workshop + Consultation Calls
10-hour, live workshop over 2 days with a live trainer via video conferencing.
There will also be twelve 1 hour calls with a live therapy consultant .
|
Approximately 10 hours (excluding breaks) over 2 days with a live trainer via video conferencing (e.g., Zoom)
Twelve 1-hour calls with a live therapy consultant via videoconferencing (e.g., Zoom)
|
|
Comparateur actif: Workshop + TherapyTrainer
10-hour, live workshop over 2 days with a live trainer via video conferencing.There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)
|
Approximately 10 hours (excluding breaks) over 2 days with a live trainer via video conferencing (e.g., Zoom)
No live meetings, but approximately 12 hours of engaging with the AI training support tool (TherapyTrainer)
Autres noms:
|
|
Comparateur actif: Web-Based Training + Consultation Calls
AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training.
There will also be twelve 1 hour calls with a live therapy consultant .
|
Twelve 1-hour calls with a live therapy consultant via videoconferencing (e.g., Zoom)
No live meetings, but approximately 8-10 hours of asynchronous training at the learner's pace over about 1 month.
|
|
Comparateur actif: Web-based Training + TherapyTrainer
AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training.
There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)
|
No live meetings, but approximately 12 hours of engaging with the AI training support tool (TherapyTrainer)
Autres noms:
No live meetings, but approximately 8-10 hours of asynchronous training at the learner's pace over about 1 month.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Provider WET Competency
Délai: Baseline to 7 months
|
A 20-item multiple choice treatment knowledge assessment.
Higher scores indicate greater knowledge of WET.
|
Baseline to 7 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Completion of Practice Cases
Délai: 4 months
|
Number of participants that complete practice cases
|
4 months
|
|
Time to complete Practice Cases
Délai: 4 months
|
Number of days to complete two training cases (real or simulated)
|
4 months
|
Collaborateurs et enquêteurs
Collaborateurs
Les enquêteurs
- Chercheur principal: Stefanie LoSavio, PhD, The University of Texas Health Science Center at San Antonio
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STUDY00002482
- HT9425-25-1-0585 (Autre subvention/numéro de financement: Department of Defense)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .